Eledon Pharmaceuticals Book Value Per Share Growth & History (ELDN)
Eledon Pharmaceuticals's book value per share was $1.07 for fiscal 2025.
View full Eledon Pharmaceuticals company overviewEledon Pharmaceuticals annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.07 | $0.96 | +851.89% |
| 2024 | 2024-12-31 | $0.11 | $4.42 | — |
| 2023 | 2023-12-31 | -$4.30 | -$6.03 | — |
| 2022 | 2022-12-31 | $1.73 | -$9.74 | −84.94% |
| 2021 | 2021-12-31 | $11.46 | -$1.11 | −8.82% |
| 2020 | 2020-12-31 | $12.57 | -$0.57 | −4.31% |
| 2019 | 2019-12-31 | $13.14 | -$14.55 | −52.54% |
| 2018 | 2018-12-31 | $27.69 | -$21.56 | −43.78% |
| 2017 | 2017-12-31 | $49.24 | $173.46 | — |
| 2016 | 2016-12-31 | -$124.21 | -$144.16 | — |
| 2015 | 2015-12-31 | $19.94 | -$729.18 | −97.34% |
| 2014 | 2014-12-31 | $749.13 | $18,899.15 | — |
| 2013 | 2013-12-31 | -$18,150.03 | $2,602.81 | — |
| 2012 | 2012-12-31 | -$20,752.83 | — | — |
Eledon Pharmaceuticals quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0.41 | -$0.43 | −51.45% |
| Q1 2026 | 2026-03-31 | $0.59 | -$0.39 | −39.99% |
| Q4 2025 | 2025-12-31 | $1.07 | $0.96 | +851.89% |
| Q3 2025 | 2025-09-30 | $0.59 | $0.10 | +19.42% |
| Q2 2025 | 2025-06-30 | $0.84 | $2.51 | — |
| Q1 2025 | 2025-03-31 | $0.98 | $3.82 | — |
| Q4 2024 | 2024-12-31 | $0.11 | $2.12 | — |
| Q3 2024 | 2024-09-30 | $0.49 | -$1.02 | −67.29% |
| Q2 2024 | 2024-06-30 | -$1.67 | -$3.57 | — |
| Q1 2024 | 2024-03-31 | -$2.84 | -$8.27 | — |
| Q4 2023 | 2023-12-31 | -$2.00 | -$3.73 | — |
| Q3 2023 | 2023-09-30 | $1.51 | -$8.74 | −85.26% |
| Q2 2023 | 2023-06-30 | $1.90 | -$8.96 | −82.51% |
| Q1 2023 | 2023-03-31 | $5.43 | -$5.93 | −52.22% |
| Q4 2022 | 2022-12-31 | $1.73 | -$9.74 | −84.94% |
| Q3 2022 | 2022-09-30 | $10.26 | -$1.68 | −14.06% |
| Q2 2022 | 2022-06-30 | $10.86 | -$1.62 | −12.98% |
| Q1 2022 | 2022-03-31 | $11.36 | -$1.49 | −11.59% |
| Q4 2021 | 2021-12-31 | $11.46 | -$1.11 | −8.82% |
| Q3 2021 | 2021-09-30 | $11.93 | -$4.94 | −29.26% |
| Q2 2021 | 2021-06-30 | $12.48 | $3.79 | +43.59% |
| Q1 2021 | 2021-03-31 | $12.85 | -$0.30 | −2.31% |
| Q4 2020 | 2020-12-31 | $12.57 | -$0.57 | −4.31% |
| Q3 2020 | 2020-09-30 | $16.87 | -$1.67 | −9.01% |
| Q2 2020 | 2020-06-30 | $8.69 | -$13.55 | −60.93% |
| Q1 2020 | 2020-03-31 | $13.16 | -$5.76 | −30.46% |
| Q4 2019 | 2019-12-31 | $13.14 | -$14.55 | −52.54% |
| Q3 2019 | 2019-09-30 | $18.54 | -$16.47 | −47.03% |
| Q2 2019 | 2019-06-30 | $22.24 | -$18.92 | −45.97% |
| Q1 2019 | 2019-03-31 | $18.92 | -$27.58 | −59.31% |
| Q4 2018 | 2018-12-31 | $27.69 | -$21.56 | −43.78% |
| Q3 2018 | 2018-09-30 | $35.01 | -$446.09 | −92.72% |
| Q2 2018 | 2018-06-30 | $41.16 | -$505.67 | −92.47% |
| Q1 2018 | 2018-03-31 | $46.49 | -$120.68 | −72.19% |
| Q4 2017 | 2017-12-31 | $49.24 | $173.46 | — |
| Q3 2017 | 2017-09-30 | $481.10 | $264.61 | +122.23% |
| Q2 2017 | 2017-06-30 | $546.83 | $268.54 | +96.49% |
| Q1 2017 | 2017-03-31 | $167.17 | -$200.76 | −54.56% |
| Q4 2016 | 2016-12-31 | -$124.21 | -$144.16 | — |
| Q3 2016 | 2016-09-30 | $216.49 | -$299.32 | −58.03% |
| Q2 2016 | 2016-06-30 | $278.30 | -$317.85 | −53.32% |
| Q1 2016 | 2016-03-31 | $367.93 | -$289.55 | −44.04% |
| Q4 2015 | 2015-12-31 | $19.94 | -$729.18 | −97.34% |
| Q3 2015 | 2015-09-30 | $515.80 | -$237.84 | −31.56% |
| Q2 2015 | 2015-06-30 | $596.15 | — | — |
| Q1 2015 | 2015-03-31 | $657.48 | — | — |
| Q4 2014 | 2014-12-31 | $749.13 | $18,899.15 | — |
| Q3 2014 | 2014-09-30 | $753.65 | — | — |
| Q4 2013 | 2013-12-31 | -$18,150.03 | — | — |
Eledon Pharmaceuticals book value per share trends
Over the last five fiscal years, Eledon Pharmaceuticals's book value per share decreased from $12.57 to $1.07, a change of -$11.50. The latest reported quarter, Q2 2026, shows $0.41.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Eledon Pharmaceuticals source filings ↗